153 related articles for article (PubMed ID: 18978464)
1. Somatic mosaicism in primary immune deficiencies.
Wada T; Candotti F
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):510-4. PubMed ID: 18978464
[TBL] [Abstract][Full Text] [Related]
2. [Revertant somatic mosaicism in primary immunodeficiency diseases].
Wada T
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):447-53. PubMed ID: 25748128
[TBL] [Abstract][Full Text] [Related]
3. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
[TBL] [Abstract][Full Text] [Related]
4. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.
Davis BR; Candotti F
Immunol Res; 2009; 44(1-3):127-31. PubMed ID: 19129986
[TBL] [Abstract][Full Text] [Related]
5. Reversion Mosaicism in Primary Immunodeficiency Diseases.
Miyazawa H; Wada T
Front Immunol; 2021; 12():783022. PubMed ID: 34868061
[TBL] [Abstract][Full Text] [Related]
6. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
[TBL] [Abstract][Full Text] [Related]
7. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006.
Stewart DM; Candotti F; Nelson DL
J Clin Immunol; 2007 Nov; 27(6):634-9. PubMed ID: 17690954
[TBL] [Abstract][Full Text] [Related]
8. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.
Wada T; Schurman SH; Jagadeesh GJ; Garabedian EK; Nelson DL; Candotti F
Blood; 2004 Sep; 104(5):1270-2. PubMed ID: 15142877
[TBL] [Abstract][Full Text] [Related]
9. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants.
Davis BR; Yan Q; Bui JH; Felix K; Moratto D; Muul LM; Prokopishyn NL; Blaese RM; Candotti F
Clin Immunol; 2010 Apr; 135(1):72-83. PubMed ID: 20123155
[TBL] [Abstract][Full Text] [Related]
10. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome.
Davis BR; Dicola MJ; Prokopishyn NL; Rosenberg JB; Moratto D; Muul LM; Candotti F; Michael Blaese R
Blood; 2008 May; 111(10):5064-7. PubMed ID: 18332229
[TBL] [Abstract][Full Text] [Related]
11. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
[TBL] [Abstract][Full Text] [Related]
12. Natural gene therapy in dystrophic epidermolysis bullosa.
van den Akker PC; Nijenhuis M; Meijer G; Hofstra RM; Jonkman MF; Pasmooij AM
Arch Dermatol; 2012 Feb; 148(2):213-6. PubMed ID: 22004882
[TBL] [Abstract][Full Text] [Related]
13. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
14. Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247.
Marin AV; Jiménez-Reinoso A; Briones AC; Muñoz-Ruiz M; Aydogmus C; Pasick LJ; Couso J; Mazariegos MS; Alvarez-Prado AF; Blázquez-Moreno A; Cipe FE; Haskologlu S; Dogu F; Morín M; Moreno-Pelayo MA; García-Sánchez F; Gil-Herrera J; Fernández-Malavé E; Reyburn HT; Ramiro AR; Ikinciogullari A; Recio MJ; Regueiro JR; Garcillán B
J Allergy Clin Immunol; 2017 Jan; 139(1):347-349.e8. PubMed ID: 27555457
[No Abstract] [Full Text] [Related]
15. In vivo reversion to normal of inherited mutations in humans.
Hirschhorn R
J Med Genet; 2003 Oct; 40(10):721-8. PubMed ID: 14569115
[TBL] [Abstract][Full Text] [Related]
16. Revertant mosaicism in the skin.
Lai-Cheong JE; McGrath JA
G Ital Dermatol Venereol; 2013 Feb; 148(1):73-82. PubMed ID: 23407079
[TBL] [Abstract][Full Text] [Related]
17. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy.
Pasmooij AM; Jonkman MF; Uitto J
Discov Med; 2012 Sep; 14(76):167-79. PubMed ID: 23021371
[TBL] [Abstract][Full Text] [Related]
18. Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma.
Nomura T
J Dermatol Sci; 2020 Feb; 97(2):94-100. PubMed ID: 31928837
[TBL] [Abstract][Full Text] [Related]
19. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
20. Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.
Evans DG; Maher ER; Baser ME
J Med Genet; 2005 Aug; 42(8):630-2. PubMed ID: 16061561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
